Nasim Sanati

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data.
  2023 L1 64/100

1 assessed by us (0 reproduced) · 21 not yet assessed — every PubMed paper on record, linked below.

• A Multi-Agent MCP Server for Cross-Modal Biomedical Embedding Alignment Evaluated on Tumor Microenvironment Characterization ↗

  2026
  not yet assessed
• Dual states of murine Bmi1-expressing intestinal stem cells drive epithelial development utilizing non-canonical Wnt signaling ↗

  Developmental Cell · 2025 · PMID 40262610
  not yet assessed
• Radiological and Biological Dictionary of Radiomics Features: Addressing Understandable AI Issues in Personalized Breast Cancer; Dictionary Version BM1.0 ↗

  2025
  not yet assessed
• FHIR as a Unifying Format for Genomic Research Data Tracking, Aggregation, and Integration ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025
  not yet assessed
• Exploring Several Novel Strategies to Enhance Prediction of Lung Cancer Survival Time ↗

  2024
  not yet assessed
• Region-of-Interest and Handcrafted vs. Deep Radiomics Feature Comparisons for Survival Outcome Prediction: Application to Lung PET/CT Imaging ↗

  2023
  not yet assessed
• VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data

  Frontiers in Immunology · 2023 · PMID 37180100
  L1 64/100
• Ontology-based representation and analysis of conditional vaccine immune responses using Omics data. ↗

  PubMed · 2023 · PMID 39583065
  not yet assessed
• Illuminate the Functions of Dark Proteins Using the Reactome‐IDG Web Portal ↗

  Current Protocols · 2023 · PMID 37467006
  not yet assessed
• Illuminating Dark Proteins using Reactome Pathways ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2023
  not yet assessed
• Illuminating Dark Proteins using Reactome Pathways ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37333417
  not yet assessed
• Dual States of Bmi1-Expressing Intestinal Stem Cells Drive Epithelial Development ↗

  SSRN Electronic Journal · 2023
  not yet assessed
• Illuminating Dark Proteins using Reactome Pathways ↗

  2022
  not yet assessed
• Dual states of Bmi1-expressing intestinal stem cells drive epithelial development and tissue regeneration ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2022
  not yet assessed
• VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2022
  not yet assessed
• The reactome pathway knowledgebase 2022 ↗

  Nucleic Acids Research · 2021 · PMID 34788843
  not yet assessed
• VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms ↗

  Frontiers in Immunology · 2021 · PMID 33777032
  not yet assessed
• CIDO ontology updates and secondary analysis of host responses to COVID-19 infection based on ImmPort reports and literature ↗

  Journal of Biomedical Semantics · 2021 · PMID 34454610
  not yet assessed
• Expansion of reactome functional interaction network to allow exposure of knowledge space of understudied proteins in the context of biological pathways ↗

  Faculty of 1000 Research Ltd · 2020
  not yet assessed
• Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma ↗

  Frontiers in Genetics · 2018 · PMID 29910823
  not yet assessed
• Gene Signatures Involved in Pathways of Head and Neck Squamous Cell Carcinoma with Higher Progression Rate ↗

  2016
  not yet assessed